Gender differences in adverse drug reactions: knowledge synthesis and exploration
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'* In the final study we assessed 1) whether the observed gender differences in spontaneously reported ADRs for a sample of drugs of the first study had already been described in other data sources, and 2) whether gender differences in pharmacokinetics (PK) and pharmacodynamics (PD) had been described that could explain the observed gender differences in ADRs' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["Adverse Drug Reaction","Database study","Diabetes","Drug dosing","Gender differences","General practice","Intensive Monitoring","oral blood glucose-lowering drugs","Pharmacodynamics","Pharmacokinetics","Pharmacovigilance","Post-marketing data","Pre-marketing data","Primary care","Regulatory science","Sex differences"]} <|eot_id|>
 Here is the Description of a dataset. Description:'* In the final study we assessed 1) whether the observed gender differences in spontaneously reported ADRs for a sample of drugs of the first study had already been described in other data sources, and 2) whether gender differences in pharmacokinetics (PK) and pharmacodynamics (PD) had been described that could explain the observed gender differences in ADRs' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
* In the final study we assessed 1) whether the observed gender differences in spontaneously reported ADRs for a sample of drugs of the first study had already been described in other data sources, and 2) whether gender differences in pharmacokinetics (PK) and pharmacodynamics (PD) had been described that could explain the observed gender differences in ADRs
Adverse Drug Reaction; Database study; Diabetes; Drug dosing; Gender differences; General practice; Intensive Monitoring; oral blood glucose-lowering drugs; Pharmacodynamics; Pharmacokinetics; Pharmacovigilance; Post-marketing data; Pre-marketing data; Primary care; Regulatory science; Sex differences